Skip to main content
JIUZHITANG CO.,LTD logo

JIUZHITANG CO.,LTD — Investor Relations & Filings

Ticker · 000989 ISIN · CNE000001394 LEI · 3003004OFW6FCZ34KN72 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,885 across all filing types
Latest filing 2025-03-27 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000989

About JIUZHITANG CO.,LTD

https://www.hnjzt.com

JIUZHITANG CO.,LTD. is a pharmaceutical enterprise specializing in the research, development, manufacturing, and distribution of Traditional Chinese Medicine (TCM). Established in 1650, the company is recognized as a time-honored brand with a heritage spanning over three centuries. Its core product portfolio includes a diverse range of TCM formulations, most notably Liuwei Dihuang Wan, donkey-hide gelatin (Ejiao), and various health supplements focused on chronic disease management and general wellness. The company operates modern production facilities that integrate traditional processing techniques with contemporary scientific standards and biotechnology. JIUZHITANG focuses on the modernization of TCM through clinical research and innovation, maintaining a distribution network that serves retail pharmacies and medical institutions to provide natural healthcare solutions.

Recent filings

Filing Released Lang Actions
关于授权利用闲置自有资金进行委托理财的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from 九芝堂股份有限公司 regarding the authorization to use idle funds for entrusted financial management. It details the investment type, amount, risk analysis, risk control measures, and the board's authorization. The document is relatively short (2084 characters) and does not contain financial statements or substantive financial data. It is an announcement about a financing activity (entrusted financial management) rather than a full financial report or detailed capital update. Given the content focuses on financing activities and capital use authorization, the most appropriate classification is Capital/Financing Update (CAP).
2025-03-27 Chinese
董事会关于2023年度内部控制审计报告否定意见涉及事项影响已消除的专项说明
Audit Report / Information Classification · 95% confidence The document is a company announcement regarding the impact and resolution of issues raised in the 2023 internal control audit report which had a negative opinion. It discusses the internal control deficiencies, corrective actions taken, and the company's assurance that the issues have been resolved. The document does not contain the audit report itself, nor detailed financial statements or comprehensive audit results. It is a disclosure about the audit report's findings and remediation status, typical of an Audit Report / Information (AR) type filing, which covers standalone audit reports and related internal control audit information. The document length is short (1772 characters), but it is not merely an announcement of a report publication; it provides substantive explanation about the audit opinion and corrective measures. Therefore, the best classification is AR (Audit Report / Information). FY 2023
2025-03-27 Chinese
关于召开2024年度业绩说明会并征集问题的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling of a 2024 annual performance explanation meeting (业绩说明会) to be held online on April 10, 2025. It references that the 2024 annual report has already been disclosed on March 28, 2025, but this document itself does not contain any financial data or the report itself. Instead, it invites investors to submit questions for the meeting and provides details about the meeting's time, format, and participants. The document length is short (801 characters) and it is clearly an announcement about an upcoming investor presentation event rather than the presentation or report itself. Therefore, this fits the category of Investor Presentation (IP) as it is a detailed presentation for investors focusing on financials, strategy, and market position, or at least the announcement of such a presentation. However, since it is announcing the meeting and inviting questions rather than providing the presentation content, it is best classified as Investor Presentation (IP) rather than Report Publication Announcement (RPA) or Regulatory Filings (RNS).
2025-03-27 Chinese
关于2024年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is a formal announcement from 九芝堂股份有限公司 regarding the 2024年度利润分配预案 (2024 annual profit distribution plan). It includes details about the profit available for distribution, the proposed cash dividend per share, the total dividend amount, and the company's share repurchase activities. The document also references the 2024年度审计报告 (2024 audit report) but does not contain the audit report itself. The text is about the profit distribution plan and dividend announcement, which is a typical content of a Notice of Dividend Amount. The document length is 3205 characters, which is relatively short and focused on dividend distribution details rather than a full financial report or audit report. Therefore, the most appropriate classification is Notice of Dividend Amount (DIV).
2025-03-27 Chinese
第九届监事会第四次会议监事书面审核意见
Regulatory Filings Classification · 95% confidence The document is a written supervisory opinion from the Supervisory Board regarding the company's 2024 Annual Report and the 2024 Internal Control Self-Evaluation Report. It confirms the accuracy, completeness, and compliance of these reports with regulatory requirements. The document itself does not contain the full annual report or financial statements but is an official opinion or certification related to these reports. Given the short length (629 characters) and the nature of the content, this is not the Annual Report itself but rather a regulatory or supervisory filing related to it. Therefore, it fits best under Regulatory Filings (RNS) as it is a formal disclosure related to compliance and supervisory review rather than the report itself.
2025-03-27 Chinese
2024年度董事会报告
Management Reports Classification · 95% confidence The document is titled as the "2024年度董事会报告" (2024 Annual Board Report) from 九芝堂股份有限公司. It details the board's activities during 2024, including the number of meetings, decisions made, execution of shareholder resolutions, and information disclosure. It also reviews the company's overall work in 2024 and outlines the main work plans for 2025. The content is a comprehensive report from the board covering company operations, governance, and strategic planning for the year, which aligns with the characteristics of a Management Reports (MDA) filing. The document length is 2116 characters, which is relatively short but contains substantive management discussion and analysis rather than just an announcement or summary. It is not a full Annual Report (10-K) as it lacks full financial statements and detailed financial performance, nor is it a simple announcement or certification. Therefore, the best fit is Management Reports (MDA).
2025-03-27 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.